Literature DB >> 19403844

Time-varying effects of prognostic factors associated with disease-free survival in breast cancer.

Loki Natarajan1, Minya Pu, Barbara A Parker, Cynthia A Thomson, Bette J Caan, Shirley W Flatt, Lisa Madlensky, Richard A Hajek, Wael K Al-Delaimy, Nazmus Saquib, Ellen B Gold, John P Pierce.   

Abstract

Early detection and effective treatments have dramatically improved breast cancer survivorship, yet the risk of relapse persists even 15 years after the initial diagnosis. It is important to identify prognostic factors for late breast cancer events. The authors investigated time-varying effects of tumor characteristics on breast-cancer-free survival using data on 3,088 breast cancer survivors from 4 US states who participated in a randomized dietary intervention trial in 1995-2006, with maximum follow-up through 15 years (median, 9 years). A piecewise constant penalized spline approach incorporating time-varying coefficients was adopted, allowing for deviations from the proportional hazards assumption. This method is more flexible than standard approaches, provides direct estimates of hazard ratios across time intervals, and is computationally tractable. Having a stage II or III tumor was associated with a 3-fold higher hazard of breast cancer than having a stage I tumor during the first 2.5 years after diagnosis; this hazard ratio decreased to 2.1 after 7.7 years, but higher tumor stage remained a significant risk factor. Similar diminishing effects were found for poorly differentiated tumors. Interestingly, having a positive estrogen receptor status was protective up to 4 years after diagnosis but detrimental after 7.7 years (hazard ratio = 1.5). These results emphasize the importance of careful statistical modeling allowing for possibly time-dependent effects in long-term survivorship studies.

Entities:  

Mesh:

Year:  2009        PMID: 19403844      PMCID: PMC2733768          DOI: 10.1093/aje/kwp077

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  17 in total

1.  Erosion of regression effect in a survival study.

Authors:  John O'Quigley; Loki Natarajan
Journal:  Biometrics       Date:  2004-06       Impact factor: 2.571

2.  Time-dependent effects on survival in breast carcinoma: results of 20 years of follow-up from the Swedish Two-County Study.

Authors:  Jane Warwick; Lazlo Tabàr; Bedrich Vitak; Stephen W Duffy
Journal:  Cancer       Date:  2004-04-01       Impact factor: 6.860

3.  A flexible approach to time-varying coefficients in the Cox regression setting.

Authors:  D J Sargent
Journal:  Lifetime Data Anal       Date:  1997       Impact factor: 1.588

4.  Score tests for homogeneity of regression effect in the proportional hazards model.

Authors:  J O'Quigley; F Pessione
Journal:  Biometrics       Date:  1989-03       Impact factor: 2.571

Review 5.  Molecular prognostic factors for breast cancer metastasis and survival.

Authors:  Francisco J Esteva; Aysegul A Sahin; Massimo Cristofanilli; Banu Arun; Gabriel N Hortobagyi
Journal:  Semin Radiat Oncol       Date:  2002-10       Impact factor: 5.934

6.  Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer.

Authors:  Donald A Berry; Constance Cirrincione; I Craig Henderson; Marc L Citron; Daniel R Budman; Lori J Goldstein; Silvana Martino; Edith A Perez; Hyman B Muss; Larry Norton; Clifford Hudis; Eric P Winer
Journal:  JAMA       Date:  2006-04-12       Impact factor: 56.272

7.  Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.

Authors: 
Journal:  Lancet       Date:  2005 May 14-20       Impact factor: 79.321

8.  Estrogen receptors and distinct patterns of breast cancer relapse.

Authors:  Kenneth R Hess; Lajos Pusztai; Aman U Buzdar; Gabriel N Hortobagyi
Journal:  Breast Cancer Res Treat       Date:  2003-03       Impact factor: 4.872

9.  Time-dependence of hazard ratios for prognostic factors in primary breast cancer.

Authors:  S G Hilsenbeck; P M Ravdin; C A de Moor; G C Chamness; C K Osborne; G M Clark
Journal:  Breast Cancer Res Treat       Date:  1998       Impact factor: 4.872

10.  Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial.

Authors:  John P Pierce; Loki Natarajan; Bette J Caan; Barbara A Parker; E Robert Greenberg; Shirley W Flatt; Cheryl L Rock; Sheila Kealey; Wael K Al-Delaimy; Wayne A Bardwell; Robert W Carlson; Jennifer A Emond; Susan Faerber; Ellen B Gold; Richard A Hajek; Kathryn Hollenbach; Lovell A Jones; Njeri Karanja; Lisa Madlensky; James Marshall; Vicky A Newman; Cheryl Ritenbaugh; Cynthia A Thomson; Linda Wasserman; Marcia L Stefanick
Journal:  JAMA       Date:  2007-07-18       Impact factor: 56.272

View more
  20 in total

Review 1.  Time course of risk factors in cancer etiology and progression.

Authors:  Esther K Wei; Kathleen Y Wolin; Graham A Colditz
Journal:  J Clin Oncol       Date:  2010-07-19       Impact factor: 44.544

2.  The impact of chemotherapy sequence on survival in node-positive invasive lobular carcinoma.

Authors:  Nina Tamirisa; Hannah V Williamson; Samantha M Thomas; Kelly E Westbrook; Rachel A Greenup; Jennifer K Plichta; Laura H Rosenberger; Terry Hyslop; Eun-Sil Shelley Hwang; Oluwadamilola M Fayanju
Journal:  J Surg Oncol       Date:  2019-05-06       Impact factor: 3.454

3.  Poor physical health predicts time to additional breast cancer events and mortality in breast cancer survivors.

Authors:  Nazmus Saquib; John P Pierce; Juliann Saquib; Shirley W Flatt; Loki Natarajan; Wayne A Bardwell; Ruth E Patterson; Marcia L Stefanick; Cynthia A Thomson; Cheryl L Rock; Lovell A Jones; Ellen B Gold; Njeri Karanja; Barbara A Parker
Journal:  Psychooncology       Date:  2011-03       Impact factor: 3.894

4.  Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study.

Authors:  Katie M O'Brien; Stephen R Cole; Chiu-Kit Tse; Charles M Perou; Lisa A Carey; William D Foulkes; Lynn G Dressler; Joseph Geradts; Robert C Millikan
Journal:  Clin Cancer Res       Date:  2010-12-15       Impact factor: 12.531

5.  Tamoxifen metabolite concentrations, CYP2D6 genotype, and breast cancer outcomes.

Authors:  L Madlensky; L Natarajan; S Tchu; M Pu; J Mortimer; S W Flatt; D M Nikoloff; G Hillman; M R Fontecha; H J Lawrence; B A Parker; A H B Wu; J P Pierce
Journal:  Clin Pharmacol Ther       Date:  2011-03-23       Impact factor: 6.875

6.  Dietary intake, supplement use, and survival among women diagnosed with early-stage breast cancer.

Authors:  Juliann Saquib; Cheryl L Rock; Loki Natarajan; Nazmus Saquib; Vicky A Newman; Ruth E Patterson; Cynthia A Thomson; Wael K Al-Delaimy; John P Pierce
Journal:  Nutr Cancer       Date:  2011       Impact factor: 2.900

7.  Ki67: a time-varying biomarker of risk of breast cancer in atypical hyperplasia.

Authors:  Marta Santisteban; Carol Reynolds; Emily G Barr Fritcher; Marlene H Frost; Robert A Vierkant; Stephanie S Anderson; Amy C Degnim; Daniel W Visscher; V Shane Pankratz; Lynn C Hartmann
Journal:  Breast Cancer Res Treat       Date:  2009-09-23       Impact factor: 4.872

8.  Breast cancer recurrence in older women five to ten years after diagnosis.

Authors:  Jaclyn L F Bosco; Timothy L Lash; Marianne N Prout; Diana S M Buist; Ann M Geiger; Reina Haque; Feifei Wei; Rebecca A Silliman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-10-20       Impact factor: 4.254

9.  A pooled analysis of post-diagnosis lifestyle factors in association with late estrogen-receptor-positive breast cancer prognosis.

Authors:  Sarah Nechuta; Wendy Y Chen; Hui Cai; Elizabeth M Poole; Marilyn L Kwan; Shirley W Flatt; Ruth E Patterson; John P Pierce; Bette J Caan; Xiao Ou Shu
Journal:  Int J Cancer       Date:  2015-12-09       Impact factor: 7.396

10.  Time-varying effects of prognostic factors associated with long-term survival in breast cancer.

Authors:  Minlu Zhang; Peng Peng; Kai Gu; Hui Cai; Guoyou Qin; Xiao Ou Shu; Pingping Bao
Journal:  Endocr Relat Cancer       Date:  2018-02-22       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.